Additionally, FDA is proposing two other restrictions around the submission of a supplemental PMTA. Underneath proposed § 1114.15(a), a supplemental PMTA could not be submitted wherever the marketing order for the first tobacco product has actually been withdrawn or has been quickly suspended or is